Featured

China Approves HUTCHMED's ORPATHYS® and TAGRISSO® Combination for Lung Cancer

HUTCHMED announced that the China National Medical Products Administration (NMPA) approved the combination of ORPATHYS® (savolitinib) and TAGRISSO® (o...

Home/KnolSights/Regulatory Approvals/China Approves HUTCHMED's ORPATHYS® and TAGRISSO® Combination for Lung Cancer